Administration of imiquimod, an interferon inducer, in asymptomatic human immunodeficiency virus-infected persons to determine safety and biologic response modification

Journal of Infectious Diseases

Volumn 178, Issue 3, 1998, Pages 858-861

  Goldstein, D ^a   Hertzog, P ^f   Tomkinson, E ^e   Couldwell, D ^b   McCarville, S ^c   Parrish, S ^f   Cunningham, P ^f   Newell, M ^d   Owens, M ^f   Cooper, D A ^f  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b Blue Mountains Sexual Hlth/HIV C   (Australia)

^c MEDTRONIC INC   (United States)

^d THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^e KING FAHD ARMED FORCES HOSPITAL   (Saudi Arabia)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ALANINE AMINOTRANSFERASE; ANTIGEN P24; ASPARTATE AMINOTRANSFERASE; BETA 2 MICROGLOBULIN; BIOLOGICAL RESPONSE MODIFIER; CD4 ANTIGEN; IMIQUIMOD; INTERFERON; INTERFERON INDUCING AGENT; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; NEOPTERIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; DRUG SAFETY; FATIGUE; FEMALE; FEVER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTENSION; INTERFERON INDUCTION; LYMPHOCYTE COUNT; MALAISE; MALE; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; VIRUS LOAD; VOMITING;

EID: 17344368048     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515343     Document Type: Article

References (15)

1. Hartshorn KL, Neumeyer D, Vogt MW, Schooley RT, Hirsch MS. Activity of interferons alpha, beta, and gamma against human immunodeficiency virus-replication in vitro. AIDS Res Hum Retroviruses 1987; 3:125-33.
2. Hirsch MS. Chemotherapy of human immunodeficiency virus infections: current practice and future prospects. J Infect Dis 1990; 161: 845-57.
3. Gendelman HE, Baca LM, Turpin J, et al. Regulation of HIV replication in infected monocytes by IFN-alpha: mechanisms for viral restriction. J Immunol 1990; 145:2669-76.
4. Lane HC, Kovacs JA, Feinberg J, et al. Antiretroviral effects of interferon alpha in AIDS-associated Kaposi's sarcoma. Lancet 1988; 2: 1218-22.
5. Lane HC, Davey V, Kovacs JA, et al. Interferon alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection: a randomised, placebo-controlled trial. Ann Intern Med 1990; 112:805-11.
6. 6/L: results of the Zidon trial. AIDS 1995; 9:1025-35.
7. Hwang SY, Hertzog PJ, Holland KA, et al. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons α and β and alters macrophage responses. Proc Natl Acad Sci USA 1995; 92:11284-8.
8. Miller R, Birmachu W, Gerster J, et al. Imiquimod: cytokine induction and antiviral activity. Int Antiviral News 1995; 3:111-3.
9. Kende M, Lupton HW, Canonico PG. Treatment of experimental viral infections with immunomodulators. Adv Biosci 1988; 53:51-63.
10. Wilt PL, Ritch PJ, Reding D, et al. Phase I trial of an oral immunomodulator and interferon inducer in cancer patients. Cancer Res 1993; 53: 5176-80.
11. Savage P, Horton V, Moore J, Owens M, Witt P, Gore ME. A phase I clinical trial of imiquimod, an oral interferon inducer, administered daily. Br J Cancer 1996; 74:1482-6.
12. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992; 41 (RR-17): 1-19.
13. Gibson SJ, Imbertson LM, Wagner TL, et al. Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609. J Interferon Cytokine Res 1995; 15:537-45.
14. Capobianchi MR, Ameglio F, Fei PC, et al. Coordinate induction of interferon alpha and gamma by recombinant HIV-1 glycoprotein 120. AIDS Res Hum Retroviruses 1993; 9:957-62.
15. 2 microglobulin in asymptomatic HIV-infected individuals. AIDS 1991; 5:289-93.